Lingating, Esterlita .

HRN: 06-81-30  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/03/2024
SODIUM FUSIDATE 20MG/G, 15G OINTMENT
04/03/2024
04/10/2024
TOPICAL
15g
TID
Infected Wound, Breast
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: